Skip to main content
KBS_Icon_questionmark link-ico


Heng Sheng started his PhD study in October 2019 in the department of Human Genetics (head professor Silvere van der Maarel) under the supervision of Associate professor Sjef Verbeek, Dr Marieke Fransen and Professor Ferry Ossendorp of the Leiden University Medical Center, the Netherlands. His PhD project focused on different cancer immunotherapy approaches exploiting tumor targeting and immunostimulatory antibodies. Heng Sheng joined Professor Sophia Karagiannis’s group in 2018 and he has been collaborating with IGEM Therapeutics working on pre-clinical development of IgE antibodies against cancer.